| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043208053 |
| P356 | DOI | 10.1038/NSMB.2965 |
| P8608 | Fatcat ID | release_rjynnkdwabgwzeyftuaf3xpcku |
| P3181 | OpenCitations bibliographic resource ID | 3966479 |
| P932 | PMC publication ID | 4351130 |
| P698 | PubMed publication ID | 25686086 |
| P5875 | ResearchGate publication ID | 272422033 |
| P50 | author | Raymond C. Stevens | Q7298638 |
| Thomas A White | Q56073471 | ||
| Haitao Zhang | Q57242845 | ||
| Raimund Fromme | Q63346869 | ||
| Nadia A. Zatsepin | Q80123959 | ||
| Jesse Coe | Q88391463 | ||
| Gye Won Han | Q88435974 | ||
| Bryan L. Roth | Q89688393 | ||
| Petra Fromme | Q89794023 | ||
| Dominik Oberthuer | Q90428016 | ||
| Shibom Basu | Q91099462 | ||
| Andrii Ishchenko | Q91767554 | ||
| Markus Metz | Q96142142 | ||
| Cornelius Gati | Q96577247 | ||
| Chelsie E. Conrad | Q103836877 | ||
| Gustavo Fenalti | Q114336928 | ||
| Dingjie Wang | Q114401575 | ||
| Patrick M Giguere | Q117222586 | ||
| Wei Liu | Q124538811 | ||
| Vsevolod Katritch | Q28317231 | ||
| Vadim Cherezov | Q28320126 | ||
| Marc Messerschmidt | Q28321841 | ||
| Sébastien Boutet | Q28321847 | ||
| Uwe Weierstall | Q28321855 | ||
| Anton Barty | Q28359711 | ||
| Oleksandr Yefanov | Q43422867 | ||
| Henry N. Chapman | Q46344491 | ||
| Daniel James | Q55777508 | ||
| P2093 | author name string | Garth J Williams | |
| John C H Spence | |||
| Peter W Schiller | |||
| Chun Hong Yoon | |||
| Dirk Tourwé | |||
| Karel Guillemyn | |||
| Steven Ballet | |||
| Cecilia Betti | |||
| P2860 | cites work | Structure of the human κ-opioid receptor in complex with JDTic | Q24308048 |
| PHENIX: a comprehensive Python-based system for macromolecular structure solution | Q24654617 | ||
| The genetic design of signaling cascades to record receptor activation | Q24657333 | ||
| Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
| Redesign of a four-helix bundle protein by phage display coupled with proteolysis and structural characterization by NMR and X-ray crystallography | Q27639826 | ||
| Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions | Q27670746 | ||
| Structure of the agonist-bound neurotensin receptor | Q27674395 | ||
| Crystal structure of the µ-opioid receptor bound to a morphinan antagonist | Q27678133 | ||
| Structure of the δ-opioid receptor bound to naltrindole | Q27679153 | ||
| Serial Femtosecond Crystallography of G Protein-Coupled Receptors | Q27680992 | ||
| Molecular control of δ-opioid receptor signalling | Q27681274 | ||
| Influence of sample pH on the conformational backbone dynamics of a pseudotripeptide (H-Tyr-Tic psi [CH2-NH]Phe-OH) incorporating a reduced peptide bond: an NMR investigation | Q70884269 | ||
| CrystFEL: a software suite for snapshot serial crystallography | Q106111061 | ||
| Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography | Q27681713 | ||
| Phasercrystallographic software | Q27860930 | ||
| Refinement of macromolecular structures by the maximum-likelihood method | Q27861011 | ||
| Features and development of Coot | Q27861079 | ||
| Crystallizing membrane proteins using lipidic mesophases | Q29616431 | ||
| Preparation of microcrystals in lipidic cubic phase for serial femtosecond crystallography. | Q30365684 | ||
| Cheetah: software for high-throughput reduction and analysis of serial femtosecond X-ray diffraction data | Q30829393 | ||
| Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomimetics | Q33540001 | ||
| Bi- or multifunctional opioid peptide drugs | Q33767037 | ||
| Opioids and their receptors: Are we there yet? | Q34437456 | ||
| Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) | Q35120622 | ||
| Dmt and opioid peptides: a potent alliance | Q35136105 | ||
| Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities. | Q37186178 | ||
| Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists | Q37342344 | ||
| Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold | Q37342753 | ||
| TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity | Q42286468 | ||
| Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice | Q44333988 | ||
| The opioid mu agonist/delta antagonist DIPP-NH(2)[Psi] produces a potent analgesic effect, no physical dependence, and less tolerance than morphine in rats | Q44352759 | ||
| Structural studies of [2',6'-dimethyl-L-tyrosine1]endomorphin-2 analogues: enhanced activity and cis orientation of the Dmt-Pro amide bond | Q44387092 | ||
| P433 | issue | 3 | |
| P921 | main subject | opioid | Q427523 |
| structural biology | Q908902 | ||
| P304 | page(s) | 265-268 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Nature Structural & Molecular Biology | Q1071739 |
| P1476 | title | Structural basis for bifunctional peptide recognition at human δ-opioid receptor | |
| P478 | volume | 22 |
| Q61809633 | : a reference-based auto-indexing algorithm for sparse serial crystallography data |
| Q38653533 | A Bright Future for Serial Femtosecond Crystallography with XFELs. |
| Q37574675 | A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists |
| Q35637848 | A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior. |
| Q47348737 | A Structural Framework for GPCR Chemogenomics: What's In a Residue Number? |
| Q35692417 | A novel inert crystal delivery medium for serial femtosecond crystallography. |
| Q96132105 | Advances in therapeutic peptides targeting G protein-coupled receptors |
| Q36084217 | Atomic resolution structure determination by the cryo-EM method MicroED. |
| Q38743944 | Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation |
| Q44341109 | Conformational Heterogeneity of Intracellular Loop 3 of the μ-opioid G-protein Coupled Receptor |
| Q38749484 | Crystallization of Membrane Proteins: An Overview |
| Q91669090 | DatView: a graphical user interface for visualizing and querying large data sets in serial femtosecond crystallography |
| Q43075987 | Designing Safer Analgesics via μ-Opioid Receptor Pathways |
| Q91742965 | Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists |
| Q47567861 | Fentanyl-related designer drugs W-18 and W-15 lack appreciable opioid activity in vitro and in vivo |
| Q36635468 | Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities. |
| Q26752403 | G Protein-Coupled Receptors (GPCRs) in Alzheimer's Disease: A Focus on BACE1 Related GPCRs |
| Q55278334 | G protein-coupled receptors: the evolution of structural insight. |
| Q38812016 | Hitchhiking on the heptahelical highway: structure and function of 7TM receptor complexes. |
| Q51037057 | Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds. |
| Q30653915 | In meso in situ serial X-ray crystallography of soluble and membrane proteins |
| Q27316812 | In meso in situ serial X-ray crystallography of soluble and membrane proteins at cryogenic temperatures |
| Q52665081 | In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease. |
| Q52315660 | Insights from molecular dynamics simulations to exploit new trends for the development of improved opioid drugs |
| Q39165104 | Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures. |
| Q101476174 | Isoprenoid-chained lipid EROCOC17+4: a new matrix for membrane protein crystallization and a crystal delivery medium in serial femtosecond crystallography |
| Q27334433 | Lipidic cubic phase injector is a viable crystal delivery system for time-resolved serial crystallography |
| Q26784007 | Membrane protein structural biology using X-ray free electron lasers |
| Q37062556 | Molecular Pharmacology of δ-Opioid Receptors |
| Q98895948 | Molecular-Level Understanding of the Somatostatin Receptor 1 (SSTR1)-Ligand Binding: A Structural Biology Study Based on Computational Methods |
| Q50905291 | Nanoscale clustering of the neurotrophin receptor TrkB revealed by super-resolution STED microscopy |
| Q38718788 | New Technologies for Elucidating Opioid Receptor Function |
| Q39332114 | New approaches towards the understanding of integral membrane proteins: A structural perspective on G protein-coupled receptors |
| Q93222349 | Non-cryogenic structure of a chloride pump provides crucial clues to temperature-dependent channel transport efficiency |
| Q64068526 | On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity |
| Q44345123 | Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge. |
| Q30393367 | Possibilities for serial femtosecond crystallography sample delivery at future light sources |
| Q36147702 | Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography |
| Q44343199 | Propagation of the Allosteric Modulation Induced by Sodium in the δ-Opioid Receptor |
| Q37108546 | Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors |
| Q64949661 | Serial Femtosecond Crystallography of G Protein-Coupled Receptors. |
| Q36110683 | Serial Femtosecond Crystallography of Membrane Proteins |
| Q36390354 | Serial Synchrotron X-Ray Crystallography (SSX). |
| Q35901032 | Serial femtosecond X-ray diffraction of enveloped virus microcrystals |
| Q36091742 | Serial femtosecond crystallography datasets from G protein-coupled receptors |
| Q30367012 | Serial femtosecond crystallography opens new avenues for Structural Biology. |
| Q30387614 | Serial femtosecond crystallography: A revolution in structural biology. |
| Q27318592 | Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides |
| Q51761770 | Structural biology of G protein-coupled receptors: new opportunities from XFELs and cryoEM. |
| Q47558272 | Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. |
| Q56674183 | Structure of the µ-opioid receptor–Gi protein complex |
| Q26331003 | Structure-based discovery of opioid analgesics with reduced side effects |
| Q36230191 | Targeting delta opioid receptors for pain treatment: drugs in phase I and II clinical development. |
| Q88737142 | The fine art of integral membrane protein crystallisation |
| Q35901023 | Time-resolved structural studies with serial crystallography: A new light on retinal proteins |
| Q92768615 | Understanding Peptide Binding in Class A G Protein-Coupled Receptors |
| Q28834461 | XFELs open a new era in structural chemical biology |
| Q41840052 | [Dmt(1)]DALDA analogues modified with tyrosine analogues at position 1. |
Search more.